"Turkey is still relatively new to mining but there are a lot of reserves and after the privatization drive, the industry grew rapidly. However, we still do not have a high enough level of exploration and there are social and environmental problems, which means it is difficult to get permits."
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.